21 CFR 864.7140

§ 864.7140 Activated whole blood clotting time tests.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 864.7140, § 864.7140 Activated whole blood clotting time tests, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/89363
Permanent ID: ys:prov:89363@1
SHA-256: cc9fe4cc2883dc5f9d73874319c14d25da948cd24536b78a8a2a224684a860aa

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Identification. An activated whole blood clotting time tests is a device, used to monitor heparin therapy for the treatment of venous thrombosis or pulmonary embolism by measuring the coagulation time of whole blood. (b) Classification. Class II (performance standards).

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.